Isocitrate dehydrogenase (IDH) inhibitor, Mutant IDH1-IN-4, Purity ≥98%

Cat. No.: X24-09-YM328

Isocitrate dehydrogenase (IDH) inhibitor, Mutant IDH1-IN-4, Purity ≥98%

Synonym: 1416270-18-2; 8-Cyclopropyl-6-[(3R)-3-cyclopropyl-4-(3-methoxypropanoyl)piperazin-1-yl]-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile; 8-Cyclopropyl-6-[(3R)-3-cyclopropyl-4-(3-methoxypropanoyl)piperazin-1-yl]-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile; Isocitrate dehydrogenase (IDH) inhibitor

  • CAS Number: 1416270-18-2
  • Compound CID: 71119107
Product Size
1 mg; 5 mg; 10 mg; 20 mg
Price
Datasheet
MSDS
Properties
Description
Mutant IDH1-IN-4 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting isocitrate dehydrogenase (IDH). The molecular weight of the compound is 438.56, and its molecular formula is C25H34N4O3.
Molecular Weight
438.56
Molecular Formula
C25H34N4O3
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
Mutant IDH1-IN-4 can be studied extensively for its potential therapeutic applications in the treatment of IDH1-mutant cancers by inhibiting the mutant enzyme activity.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0